- Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis2010 | Central Library of Charles University
- Expresion of DD3PCA3 (Differential Display Code 3) mRNA in tissue of patients with prostate cancer and benign prostatic hyperplasia2010 | Central Library of Charles University
- Expresion of DD3PCA3 (Differential Display Code 3) mRNA in tissue of patients with prostate cancer and benign prostatic hyperplasia2010 | Faculty of Medicine in Pilsen
- Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis2010 | First Faculty of Medicine
- Differential Display Code 3 (DD3/PCA3) in Prostate Cancer Diagnosis2010 | Second Faculty of Medicine
- Minimally invasive surgical methods for the treatment of benign prostatic hyperplasia, as an alternative to classic desobstructive procedures2020 | First Faculty of Medicine
- Benign prostatic hyperplasia and lower urinary tract symptoms in men: etiology, pathophysiology and epidemiology2014 | First Faculty of Medicine, Third Faculty of Medicine
- New trends in the conservative management of benign prostatic hyperplasia2006 | Third Faculty of Medicine
- Benign prostatic hyperplasia - latest pharmacotherapy options, risks and limitations of treatment2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Effects of a hexane extract of saw palmetto (Serenoa repens, Permixon(R) 160mg, available as Capistan(R) in Czech Republic) on inflammatory biomarkers in treating symptoms associated with benign prostatic hyperplasia2016 | First Faculty of Medicine
- New trends in the surgical treatment of benign prostatic hyperplasia - minimally invasive methods of therapy2006 | Third Faculty of Medicine
- Laparoscopic urinary bladder diverticulectomy combined with photoselective vaporisation of the prostate2015 | Faculty of Medicine in Pilsen
- Comparison of therapy benign prostatic hyperplasia yesterday and today2017 | Faculty of Medicine in Hradec Králov é
- Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression2008 | First Faculty of Medicine, Third Faculty of Medicine
- Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer2007 | Third Faculty of Medicine
- Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)2021 | Central Library of Charles University
- Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study2011 | Third Faculty of Medicine